Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mangold

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
JAMA Dermatology|July 20, 2022
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical TrialEllen J Kim, Aaron R Mangold, Jennifer A DeSimone, et al.
The New England Journal of Medicine|March 30, 2026
A Phase 3 Trial of Brepocitinib in DermatomyositisRuth Ann Vleugels, Julie J Paik, Iazsmin Bauer Ventura, et al.
The British Journal of Dermatology|October 22, 2024
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanomaErin McGillivray, Karam Ashouri, Eftychia Chatziioannou, et al.
Cancer|October 4, 2018
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trialsJoanne M Jeter, Tawnya L Bowles, Clara Curiel-Lewandrowski, et al.
Melanoma Management|August 1, 2017
Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversyMariah M Johnson, Sancy A Leachman, Lisa G Aspinwall, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
JAMA Dermatology|July 20, 2022
Efficacy and Safety of Topical Hypericin Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma (Mycosis Fungoides): The FLASH Phase 3 Randomized Clinical TrialEllen J Kim, Aaron R Mangold, Jennifer A DeSimone, et al.
The New England Journal of Medicine|March 30, 2026
A Phase 3 Trial of Brepocitinib in DermatomyositisRuth Ann Vleugels, Julie J Paik, Iazsmin Bauer Ventura, et al.
The British Journal of Dermatology|October 22, 2024
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanomaErin McGillivray, Karam Ashouri, Eftychia Chatziioannou, et al.
Cancer|October 4, 2018
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trialsJoanne M Jeter, Tawnya L Bowles, Clara Curiel-Lewandrowski, et al.
Melanoma Management|August 1, 2017
Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversyMariah M Johnson, Sancy A Leachman, Lisa G Aspinwall, et al.
Pageof 11